Skip to content
healthcare.dev

REGOXIDINE (FOR MEN)

NDC 57483-165, MINOXIDIL, aerosol, foam, from INNOVUS PHARMACEUTICALS, INC..

Product NDC
57483-165
Status
Listed
Labeler
INNOVUS PHARMACEUTICALS, INC.
Dosage form
AEROSOL, FOAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA218616
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57483-165 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MINOXIDIL50 mg/g

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
57483-165-11574830165111 CAN in 1 CARTON (57483-165-11) / 60 g in 1 CAN (57483-165-01)
57483-165-13574830165133 CAN in 1 CARTON (57483-165-13) / 60 g in 1 CAN (57483-165-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 57483-165 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57483-165 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57483-165. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.